The Unrestricted Use of Sirolimus- and Paclitaxel-Eluting Stents Results in Better Clinical Outcomes During 6-Year Follow-Up Than Bare-Metal Stents by Simsek, Cihan, MD, Magro, Michael, MD, Boersma, Eric, PhD, Onuma, Yoshinobu, MD, Nauta, Sjoerd T., MSc, Gaspersz, Marcia P., MSc, van der Giessen, Willem J., MD, PhD, van Domburg, Ron T., PhD, Serruys, Patrick W., MD, PhD

Get full text